Work

Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer

Year: 2026

Type: article

Source: Oncogene

DOI: 10.1038/s41388-026-03969-5

Authors: Michela Perego, Jozef Madzo, Andrew V. Kossenkov, F. Cansu Atilgan, Marcella Tazzari, Maria Maddalena Tumedei, Francesco Limarzi, Cristian Lolli, Giorgia Gurioli, Alessandro Fatatis, Mary V. Iacocca, Nicholas J. Petrelli, Justine J. Jacobi, David W. Goodrich, Lucia R. Languino, Dario C. Altieri

Institutions: The Wistar Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Azienda Unità Sanitaria Locale Della Romagna, Ospedale G.B. Morgagni - L.Pierantoni, Drexel University, Christiana Care Health System, Roswell Park Comprehensive Cancer Center, Thomas Jefferson University, Sidney Kimmel Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Prostate Cancer Foundation, National Cancer Institute, Center for Scientific Review

Awards: G5665847971, G569453731, G7010336509

OpenAlex ID: W7204827231

FWCI:

Cites: 84

Cited by:

Related to: